Sporadic inclusion body myositis in the rheumatology clinic

Sporadic inclusion body myositis (sIBM) is a progressive and insidious skeletal muscle disorder characterized classically by the quadriceps, wrist, and finger flexor weakness. The main irreversible complications of sIBM are dysphagia and walking difficulties. The disease affects more men than women,...

Full description

Bibliographic Details
Main Authors: Fernando Henrique Carlos de Souza, Gustavo Luiz Behrens Pinto, Jean Marcos de Souza, Pablo Arturo Olivo Pallo, Leonardo Santos Hoff, Samuel Katsuyuki Shinjo
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=6;spage=145;epage=152;aulast=de
id doaj-2bc9d93215214e3fa1c9f2aab754004e
record_format Article
spelling doaj-2bc9d93215214e3fa1c9f2aab754004e2021-02-03T06:20:56ZengWolters Kluwer Medknow PublicationsIndian Journal of Rheumatology0973-36980973-37012020-01-0115614515210.4103/injr.injr_80_20Sporadic inclusion body myositis in the rheumatology clinicFernando Henrique Carlos de SouzaGustavo Luiz Behrens PintoJean Marcos de SouzaPablo Arturo Olivo PalloLeonardo Santos HoffSamuel Katsuyuki ShinjoSporadic inclusion body myositis (sIBM) is a progressive and insidious skeletal muscle disorder characterized classically by the quadriceps, wrist, and finger flexor weakness. The main irreversible complications of sIBM are dysphagia and walking difficulties. The disease affects more men than women, and the symptom onset mainly occurs between 50 and 70 years of age. Due to its slow progression, sIBM diagnosis is frequently delayed and therefore misdiagnosed as other muscle diseases. sIBM remains refractory to treatment (e.g., glucocorticoid, and immunosuppressive/immunomodulatory/immunobiological drugs). Although there have been no robust clinical trials, training exercise/physiotherapy should be prescribed regularly in sIBM patients.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=6;spage=145;epage=152;aulast=deidiopathic inflammatory myopathiesinclusion body myositismyopathiesmyositisreview
collection DOAJ
language English
format Article
sources DOAJ
author Fernando Henrique Carlos de Souza
Gustavo Luiz Behrens Pinto
Jean Marcos de Souza
Pablo Arturo Olivo Pallo
Leonardo Santos Hoff
Samuel Katsuyuki Shinjo
spellingShingle Fernando Henrique Carlos de Souza
Gustavo Luiz Behrens Pinto
Jean Marcos de Souza
Pablo Arturo Olivo Pallo
Leonardo Santos Hoff
Samuel Katsuyuki Shinjo
Sporadic inclusion body myositis in the rheumatology clinic
Indian Journal of Rheumatology
idiopathic inflammatory myopathies
inclusion body myositis
myopathies
myositis
review
author_facet Fernando Henrique Carlos de Souza
Gustavo Luiz Behrens Pinto
Jean Marcos de Souza
Pablo Arturo Olivo Pallo
Leonardo Santos Hoff
Samuel Katsuyuki Shinjo
author_sort Fernando Henrique Carlos de Souza
title Sporadic inclusion body myositis in the rheumatology clinic
title_short Sporadic inclusion body myositis in the rheumatology clinic
title_full Sporadic inclusion body myositis in the rheumatology clinic
title_fullStr Sporadic inclusion body myositis in the rheumatology clinic
title_full_unstemmed Sporadic inclusion body myositis in the rheumatology clinic
title_sort sporadic inclusion body myositis in the rheumatology clinic
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Rheumatology
issn 0973-3698
0973-3701
publishDate 2020-01-01
description Sporadic inclusion body myositis (sIBM) is a progressive and insidious skeletal muscle disorder characterized classically by the quadriceps, wrist, and finger flexor weakness. The main irreversible complications of sIBM are dysphagia and walking difficulties. The disease affects more men than women, and the symptom onset mainly occurs between 50 and 70 years of age. Due to its slow progression, sIBM diagnosis is frequently delayed and therefore misdiagnosed as other muscle diseases. sIBM remains refractory to treatment (e.g., glucocorticoid, and immunosuppressive/immunomodulatory/immunobiological drugs). Although there have been no robust clinical trials, training exercise/physiotherapy should be prescribed regularly in sIBM patients.
topic idiopathic inflammatory myopathies
inclusion body myositis
myopathies
myositis
review
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=6;spage=145;epage=152;aulast=de
work_keys_str_mv AT fernandohenriquecarlosdesouza sporadicinclusionbodymyositisintherheumatologyclinic
AT gustavoluizbehrenspinto sporadicinclusionbodymyositisintherheumatologyclinic
AT jeanmarcosdesouza sporadicinclusionbodymyositisintherheumatologyclinic
AT pabloarturoolivopallo sporadicinclusionbodymyositisintherheumatologyclinic
AT leonardosantoshoff sporadicinclusionbodymyositisintherheumatologyclinic
AT samuelkatsuyukishinjo sporadicinclusionbodymyositisintherheumatologyclinic
_version_ 1724288958445125632